Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07408245 · ClinicalTrials.gov registry record · NA
Effects of Biocidin on Oral Biofilms
A NA study of Biofilm, sponsored by OvationLab.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07408245: Recruiting NA study of Biofilm, sponsored by OvationLab.
NCT07408245 is a NA study of Biofilm that is actively recruiting participants, run by OvationLab. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07408245, a NA study of Biofilm, is actively recruiting participants, sponsored by OvationLab.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to evaluate the effects of Biocidin liquid on oral biofilms among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of two weeks of supplementation with label dosing of Biocidin liquid on oral biofilms as assessed by SimplyPERIO (Spectrum Solutions, Salt Lake City, UT).
Primary Outcome
SimplyPERIO - Oral biofilm microorganism test results are categorized as "low", "medium", and "high".
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Biocidin Liquid
Study Locations (1)
Virginia
- OvationLab - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-17 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT07408245 shows while recruiting
NCT07408245 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Biofilm appearing as the primary indexed condition, and to 1 intervention - of which Biocidin Liquid is the first listed.
NCT07408245 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT07408245 about?
NCT07408245 is a clinical study titled "Effects of Biocidin on Oral Biofilms". The primary purpose of this study is to evaluate the effects of Biocidin liquid on oral biofilms among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of two weeks of supplementation with label dosing of Biocidin liquid on oral biofilms as assessed ...
What is the current status of trial NCT07408245?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-17. Estimated completion is 2026-04.
What conditions does trial NCT07408245 study?
This clinical trial studies the following conditions: Biofilm.
What interventions are being tested in trial NCT07408245?
The interventions under investigation include: Biocidin Liquid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07408245?
This trial is sponsored by OvationLab, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07408245 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07408245's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI